HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noriyuki Ozaki Selected Research

Insulin Resistance

3/2007Central administration of melanocortin agonist increased insulin sensitivity in diet-induced obese rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Noriyuki Ozaki Research Topics

Disease

14Hyperalgesia
01/2022 - 09/2005
7Pain (Aches)
11/2019 - 09/2005
3Neuralgia (Stump Neuralgia)
01/2022 - 07/2007
3Hypersensitivity (Allergy)
01/2022 - 11/2019
3Myalgia
11/2013 - 11/2008
3Neoplasms (Cancer)
10/2012 - 09/2005
2Inflammation (Inflammations)
01/2022 - 09/2017
2Peripheral Nervous System Diseases (PNS Diseases)
01/2014 - 05/2010
2Body Weight (Weight, Body)
01/2010 - 10/2007
2Obesity
01/2010 - 10/2007
2Polyuria
05/2009 - 11/2008
1Botulism
01/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1Rupture
01/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2022
1Chronic Pain
01/2021
1Glioma (Gliomas)
01/2020
1Demyelinating Diseases (Demyelinating Disease)
01/2019
1Diabetes Mellitus
01/2018
1Arthritis (Polyarthritis)
09/2017
1Atrophy
01/2016
1Cold Hypersensitivity
01/2014
1Carcinoma (Carcinomatosis)
01/2014
1Colorectal Neoplasms (Colorectal Cancer)
01/2014
1Musculoskeletal Pain
11/2013
1Diabetes Insipidus
05/2009
1Polydipsia
11/2008
1Nephrogenic Diabetes Insipidus
11/2008
1Visceral Pain
04/2008
1Insulin Resistance
03/2007
1Fibrosis (Cirrhosis)
11/2006

Drug/Important Bio-Agent (IBA)

3Nerve Growth Factor (NGF)IBA
09/2018 - 10/2011
3Morphine (MS Contin)FDA LinkGeneric
09/2017 - 08/2008
2Adenosine Triphosphate (ATP)IBA
01/2022 - 01/2008
2Acid Sensing Ion ChannelsIBA
11/2019 - 11/2008
2Analgesics (Analgesic Drugs)IBA
09/2018 - 09/2017
2Ion Channels (Ion Channel)IBA
05/2010 - 11/2008
2Vasopressins (Vasopressin)IBA
05/2009 - 11/2008
2capsazepineIBA
08/2008 - 09/2005
2TRPV Cation ChannelsIBA
09/2006 - 09/2005
1Amino AcidsFDA Link
01/2022
1CathepsinsIBA
01/2022
1Choline (Choline Chloride)IBA
01/2022
1Botulinum Toxins (Botulinum Toxin)IBA
01/2022
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
01/2022
1Clodronic Acid (Clodronate)IBA
01/2022
1HhAntag691IBA
01/2022
1betaninIBA
01/2021
1Neutralizing AntibodiesIBA
11/2019
1Corticotropin-Releasing HormoneIBA
11/2019
1Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
11/2019
1CytokinesIBA
11/2019
1Interleukin-6 (Interleukin 6)IBA
11/2019
1CuprizoneIBA
01/2019
1Streptozocin (Streptozotocin)FDA Link
01/2018
1INCB3344IBA
01/2018
1Chemokine ReceptorsIBA
01/2018
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2016
1sperm releasing substanceIBA
01/2016
1NC-4016IBA
01/2014
11,2-cyclohexanediamine (dach)IBA
01/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2014
1MicellesIBA
01/2014
1OxalatesIBA
01/2014
1PlatinumIBA
01/2014
1Platinum Compounds (Compounds, Platinum)IBA
01/2014
1NitrogenIBA
10/2012
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
10/2011
1staurosporine aglycone (K252a)IBA
10/2011
1Cisplatin (Platino)FDA LinkGeneric
05/2010
1GhrelinIBA
01/2010
1Messenger RNA (mRNA)IBA
05/2009
1Neurophysins (Neurophysin I)IBA
05/2009
1Arginine Vasopressin (Argipressin)IBA
05/2009
1Carrier Proteins (Binding Protein)IBA
05/2009
1CarrageenanIBA
11/2008
1LithiumIBA
11/2008
1Aquaporin 2IBA
11/2008
1Ruthenium RedIBA
08/2008
1Mitogen-Activated Protein KinasesIBA
04/2008
1Protein Kinases (Protein Kinase)IBA
04/2008
1Mitogen-Activated Protein Kinase 3IBA
04/2008
1GABA-B Receptor AgonistsIBA
10/2007
1Neuropeptide YIBA
10/2007
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
10/2007
1Indicators and Reagents (Reagents)IBA
10/2007
1BaclofenFDA LinkGeneric
10/2007
1Purinergic P2X3 ReceptorsIBA
07/2007
1Insulin (Novolin)FDA Link
03/2007
1melanotan-IIIBA
03/2007
1MelanocortinsIBA
03/2007
1Purinergic P2 Receptors (ADP Receptor)IBA
09/2006
1Calcitonin Gene-Related PeptideIBA
09/2006

Therapy/Procedure

3Therapeutics
09/2018 - 07/2007
2Ligation
01/2016 - 07/2007
2Intramuscular Injections
11/2013 - 11/2008
1Craniotomy
01/2020
1Drug Therapy (Chemotherapy)
01/2014
1Injections
11/2013
1Denervation
11/2006